Compare GIB & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GIB | STE |
|---|---|---|
| Founded | 1976 | 1985 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.5B | 25.9B |
| IPO Year | N/A | 1992 |
| Metric | GIB | STE |
|---|---|---|
| Price | $92.42 | $263.47 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 9 |
| Target Price | $117.00 | ★ $268.25 |
| AVG Volume (30 Days) | 333.4K | ★ 674.3K |
| Earning Date | 11-05-2025 | 11-05-2025 |
| Dividend Yield | 0.48% | ★ 0.96% |
| EPS Growth | 0.55 | ★ 59.39 |
| EPS | 5.28 | ★ 6.97 |
| Revenue | ★ $11,424,213,683.00 | $5,702,415,000.00 |
| Revenue This Year | $8.32 | $9.24 |
| Revenue Next Year | $4.41 | $6.30 |
| P/E Ratio | ★ $16.79 | $37.72 |
| Revenue Growth | ★ 8.43 | 7.08 |
| 52 Week Low | $84.00 | $200.98 |
| 52 Week High | $122.79 | $268.60 |
| Indicator | GIB | STE |
|---|---|---|
| Relative Strength Index (RSI) | 65.72 | 59.06 |
| Support Level | $87.95 | $256.68 |
| Resistance Level | $89.50 | $268.60 |
| Average True Range (ATR) | 1.52 | 4.64 |
| MACD | 0.60 | -0.69 |
| Stochastic Oscillator | 91.53 | 65.59 |
CGI is a Canada-based IT-services provider with an embedded position in North America and Europe. The company is one of the major IT suppliers to different levels of government around the world. It offers a broad portfolio of services such as consulting, systems integration, application maintenance, and business process services to governments and the private sector. With offices in over 40 countries, CGI follows a balanced global delivery model with most consultants in client proximity.
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.